ScreenerHero

RDY Dr. Reddy's Laboratories Ltd Common Stock

NYSE · US · Healthcare · Drug Manufacturers - Specialty & Generic · drreddys.com
12.29USD+0.32%Mkt Cap: 10.20B $P/E: 29.17

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8
SFZN
Siegfried Holding AG
$3.47BUSDP/E 17.7

Key Statistics

Company
Market Cap10.20B USD
Enterprise Value54.93B USD
Revenue (TTM)331.19B USD
Gross Profit177.26B USD
Net Income (TTM)42.85B USD
Revenue/Share66.41 USD
Last Price12.29 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees27.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)29.17
P/E (Forward)18.89
PEG1.63
EV/EBITDA1.00
EV/Revenue0.17
P/S0.03
P/B15.27
EPS (TTM)0.44
EPS (Forward)0.65
52W Range
11.3622% of range15.67
52W High15.67 USD
52W Low11.36 USD
Profitability
Gross Margin52.77%
Oper. Margin4.25%
EBITDA Margin16.51%
Profit Margin12.76%
ROE11.36%
ROA7.40%
Growth
Revenue Growth-5.60%
Earnings Growth-68.70%
Cash Flow & Leverage
Operating CF56.76B USD
CapEx (TTM)38.42B USD
FCF Margin-1.18%
FCF Yield-38.31%
Net Debt-9.47B USD
Net Debt/EBITDA-0.17
Balance Sheet
Debt/Equity0.21
Current Ratio1.90
Quick Ratio1.16
Book Value/Sh0.80 USD
Cash/Share16.32 USD
Dividends
Fwd Div Rate0.08 USD
Trail. Div Rate8.00 USD
Div. Yield0.68%
5Y Avg Yield0.65%
Payout Ratio19.65%
Ex-Div DateJul 9, 2026
Pay DateAug 5, 2026
Splits
Last Split5:1
Split DateNov 5, 2024
Analyst Consensus
Rating—
Target (Mean)13.29 USD
Upside (mean)+8.2%
Target Range11.29 USD – 15.30 USD
11.29+8.2% to mean15.30
# Analysts5
Ownership
Shares Out.832.99M
Float3.59B
Insiders0.00%
Institutions16.01%
Short Interest
Short Ratio10.9d
Short % Float4.22%
Short % Out.3.48%
Shares Short28.96M
Short (prev mo.)22.51M
Technical
SMA 5012.13 (+1.3%)
SMA 20013.29 (-7.5%)
Beta0.24
S&P 52W Chg14.58%
Avg Vol (30d)2.64M
Avg Vol (10d)3.39M
Technical Indicators
RSI (14)49.7
MACD0.0775
MACD Signal0.0462
MACD Hist.+0.0313
BB Upper12.85 USD
BB Middle12.16 USD
BB Lower11.47 USD
BB Width11.35%
ATR (14)0.2746 USD
Vol Ratio (20d)1.22x